
Two Biotech Startups to Raise $70m on Wall Street
Bio Blast and Galmed have both filed prospectus with the U.S. Securities and Exchange Commission.
comments
Print
Want to enjoy 'Zen' reading - with no ads and just the article? Subscribe today
Subscribe now